Subjective and objective measures in the treatment of hemifacial spasm with onabotulinumtoxina

Ophthalmic Plastic and Reconstructive Surgery

Volumn 32, Issue 2, 2016, Pages 133-137

  Chundury, Rao V ^a   D'Angelo, Alexander S ^a   Couch, Steven M ^b   Holds, John B ^a,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Ophthalmic Plastic and Cosmetic Surgery Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ACETYLCHOLINE RELEASE INHIBITOR;

ADULT; AGED; FACIAL CLINIMETRIC EVALUATION SCALE; FEMALE; FOLLOW UP; HEMIFACIAL SPASM; HUMAN; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH; MUSCULOSKELETAL DISEASE ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SOCIAL STATUS; SUNNYBROOK FACIAL GRADING SYSTEM; SYNKINESIS; VOLUNTARY MOVEMENT; DRUG EFFECTS; EXTRAOCULAR MUSCLE; FACE MUSCLE; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; VERY ELDERLY;

ACETYLCHOLINE RELEASE INHIBITORS; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; FACIAL MUSCLES; FEMALE; HEMIFACIAL SPASM; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; OCULOMOTOR MUSCLES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SYNKINESIS;

EID: 84961943016     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000443     Document Type: Review

References (21)

1. Campbell E, Keedy C. Hemifacial spasm; a note on the etiology in two cases. J Neurosurg 1947;4:342-7.
2. Jannetta PJ, Abbasy M, Maroon JC, et al. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg 1977;47:321-8.
3. Nagata S, Fujii K, Nomura T, et al. Hemifacial spasm caused by CP angle AVM associated with ruptured aneurysm in the feeding artery-case report. Neurol Med Chir (Tokyo) 1991;31:406-9.
4. Nagata S, Matsushima T, Fujii K, et al. Hemifacial spasm due to tumor, aneurysm, or arteriovenous malformation. Surg Neurol 1992;38:204-9.
5. Kuroki A, Møller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir (Wien) 1994;126:149-57.
6. Colosimo C, Bologna M, Lamberti S, et al. A comparative study of primary and secondary hemifacial spasm. Arch Neurol 2006;63:441-4.
7. Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988;49:151-76.
8. Reimer J, Gilg K, Karow A, et al. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 2005;111:64-70.
9. Jannetta PJ. Cranial rhizopathies. In: Youmans JR, ed. Neurological Surgery. 3rd ed. Philadelphia, PA: W.B. Saunders, 1990:4169-82.
10. Auger RG, Piepgras DG, Laws ER Jr. Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patients. Mayo Clin Proc 1986;61:640-4.
11. Hanakita J, Kondo A. Serious complications of microvascular decompression operations for trigeminal neuralgia and hemifacial spasm. Neurosurgery 1988;22:348-52.
12. Huang CI, Chen IH, Lee LS. Microvascular decompression for hemifacial spasm: analyses of operative findings and results in 310 patients. Neurosurgery 1992;30:53-6; discussion 56-7.
13. Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993;33:316-9.
14. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Eur Arch Otorhinolaryngol 1994;S180-S181
15. Kayhan FT, Zurakowski D, Rauch SD. Toronto Facial Grading System: interobserver reliability. Otolaryngol Head Neck Surg 2000;122:212-5.
16. Kanerva M, Poussa T, Pitkäranta A. Sunnybrook and House-Brackmann Facial Grading Systems: intrarater repeatability and interrater agreement. Otolaryngol Head Neck Surg 2006;135:865-71.
17. Kahn JB, Gliklich RE, Boyev KP, et al. Validation of a patientgraded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope 2001;111:387-98.
18. Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope 2007;117:923-6.
19. Toffola ED, Furini F, Redaelli C, et al. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010;32:1414-8.
20. Cecini M, Pavese C, Comelli M, et al. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A. Plast Reconstr Surg 2013;132:1255-64.
21. Setthawatcharawanich S, Sathirapanya P, Limapichat K, et al. Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. Qual Life Res 2011;20:1519-23.